Development and validation of a clinical decision-making aid for screening bowel symptoms in community pharmacies
MetadataShow full item record
This is the accepted version of the following article: Sriram, D. and McManus, A. and Emmerton, L. and Parsons, R. and Jiwa, M. 2014. Development and validation of a clinical decision-making aid for screening bowel symptoms in community pharmacies. Journal of Evaluation in Clinical Practice. 20 (3): pp. 260-266, which has been published in final form at http://doi.org/10.1111/jep.12120
Rationale, aims and objectives: Bowel symptoms are common, and community pharmacies are an ideal setting for health advice about these symptoms. The aim of this study was to develop and validate a questionnaire for use with adults presenting to community pharmacies with lower bowel symptoms. The purpose of the questionnaire was to stratify people into those requiring medical follow-up for symptoms and those with self-limiting symptoms. Method: A self-administered questionnaire, named the Jodi Lee test (JLT), was developed in three stages – review of the literature, questionnaire design and statistical validation – against a validated screening tool, the patient consultation questionnaire (PCQ), to assess the sensitivity and specificity of JLT. The questionnaire was developed to be simple, easy for all pharmacy staff to use and require no score calculation. Its application was designed to facilitate referral from pharmacy assistants to pharmacists and from pharmacists to medical practitioners. Results: The questionnaire comprises eight questions. It has a Flesh–Kincaid reading score of 79.5. By considering different score thresholds on the PCQ, a receiver operator characteristic (ROC) curve was calculated to assess the effectiveness of the JLT. From a sample of 118 subjects, the area under the ROC curve was 0.94. At a threshold score of 30 on the PCQ, the sensitivity was 100%. The specificity was 65%. Conclusion: The JLT has high sensitivity for identifying patients with symptoms of serious bowel disease. It is also likely to identify patients who have symptoms of relatively benign disease who would benefit from medical advice.
Showing items related by title, author, creator and subject.
Jiwa, Moyez; Hughes, Jeffery; Sriram, Deepa; Cecchele, G.; Cooke, J.; Ng, N.; Hewitt, Vivien (2011)Background: Innovations that help the pharmacist identify which patients with lower bowel symptoms should be referred to a doctor may reduce delayed presentation to medical practitioners. This study reports several methods ...
Sriram, Deepa; McManus, Alexandra; Emmerton, Lynne; Parsons, Richard; Jiwa, Moyez (2015)BACKGROUND: To expedite diagnosis of serious bowel disease, efforts are required to signpost patients with high-risk symptoms to appropriate care. Community pharmacies are a recognised source of health advice regarding ...
Piloting and validating an innovation to triage patients presenting with cough to community pharmacies in Western AustraliaJiwa, Moyez; Hughes, Jeff; Sriram, Deepa; Birring, S.; Meng, Xingqiong (Rosie); Cecchele, G.; Cooke, J.; Ng, N. (2012)Aim: To develop a tool to assist community pharmacists to triage patients presenting with cough and to validate this against an established cough-specific quality of life (QoL) measure. Methods: A decision-support tool, ...